On Tuesday, April 30, Mercedes Meyer will speak in a Strafford live CLE webinar, “March-in Power and Patent Rights: Bayh-Dole Act, NIST Framework, Implications for Patent Rights and Innovations,” from 1 – 2:30 PM EDT.
In December 2023, the White House announced its framework on how to use these march-in rights to reduce drug costs. In February 2024, the FTC threw its support to the use of march-in rights as a way to control pharma pricing. The National Institute of Standards and Technology published a draft Framework for Considering the Exercise of March-In Rights. In a policy shift, the framework calls on federal agencies to consider “unreasonable pricing” when determining whether to exercise march-in rights.
The panel will guide patent counsel on using march-in rights as a mechanism to lower drug prices. The panel will review the Bayh-Dole Act and the NIST framework for using march-in rights, and discuss the implications and concerns for patent rights, patent holders, and innovation.
Additionally, Mercedes and her co-presenters will review other key issues:
- How can the government use the Bayh-Dole Act to control drug pricing?
- What impact will the call for consideration of unreasonable pricing have on the question of using march-in rights?
- What will the use of march-in rights mean for patent rights? Patent holders?
For more information or to register, click here.
